We are live on ! Find out more
ADIM

Alpha DNA Investment Management Portfolio holdings

AUM $8.98M
1-Year Est. Return 26.05%
This Fund
S&P 500
This Quarter Est. Return
+4.28%
1 Year Est. Return
+26.05%
3 Year Est. Return
+134.39%
5 Year Est. Return
10 Year Est. Return
AUM
$257M
AUM Growth
-$13.3M
Cap. Flow
-$15.3M
Cap. Flow %
-5.95%
Top 10 Hldgs %
43.17%
Holding
259
New
67
Increased
65
Reduced
68
Closed
57

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$2.62M
2
MCD icon
McDonald's
MCD
+$2.54M
3
MDLZ icon
Mondelez International
MDLZ
+$2.52M
4
CI icon
Cigna
CI
+$2.32M
5
JPM icon
JPMorgan Chase
JPM
+$2.18M

Sector Composition

Rank Sector Weight
1 Technology 15.39%
2 Financials 13.15%
3 Healthcare 9.82%
4 Consumer Discretionary 6.3%
5 Industrials 5.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CBSH icon
151
Commerce Bancshares
CBSH
$8.46B
$417K 0.16%
+8,235
New +$407K
AFRM icon
152
Affirm
AFRM
$25.7B
$415K 0.16%
+13,727
New +$440K
BASE
153
DELISTED
Couchbase
BASE
$414K 0.16%
22,677
+2,641
+13% +$61.5K
TARS icon
154
Tarsus Pharmaceuticals
TARS
$2.97B
$412K 0.16%
15,174
+1,261
+9% +$42.4K
LNTH icon
155
Lantheus
LNTH
$6.59B
$412K 0.16%
+5,127
New +$376K
BLBD icon
156
Blue Bird Corp
BLBD
$2.08B
$411K 0.16%
+7,634
New +$352K
IAS
157
DELISTED
Integral Ad Science
IAS
$411K 0.16%
+42,274
New +$405K
ODD icon
158
ODDITY Tech
ODD
$578M
$409K 0.16%
+10,411
New +$388K
ANF icon
159
Abercrombie & Fitch
ANF
$5.26B
$409K 0.16%
+2,298
New +$333K
MRVI icon
160
Maravai LifeSciences
MRVI
$906M
$408K 0.16%
+57,037
New +$492K
VSXY
161
Victoria's Secret
VSXY
$7.69B
$408K 0.16%
+23,107
New +$440K
JHG
162
DELISTED
Janus Henderson
JHG
$408K 0.16%
+12,101
New +$397K
OUST icon
163
Ouster
OUST
$3.31B
$407K 0.16%
+41,415
New +$419K
GATO
164
DELISTED
Gatos Silver, Inc.
GATO
$404K 0.16%
+38,675
New +$409K
WMS icon
165
Advanced Drainage Systems
WMS
$10.8B
$403K 0.16%
+2,513
New +$420K
AEO icon
166
American Eagle Outfitters
AEO
$2.94B
$400K 0.16%
20,025
-5,198
-21% -$119K
ANAB icon
167
AnaptysBio
ANAB
$1.69B
$399K 0.15%
+15,920
New +$371K
ASPN icon
168
Aspen Aerogels
ASPN
$505M
$398K 0.15%
+16,686
New +$392K
CR icon
169
Crane Co
CR
$12.8B
$394K 0.15%
+2,720
New +$385K
AMBA icon
170
Ambarella
AMBA
$3.7B
$394K 0.15%
7,305
-2,743
-27% -$136K
OLED icon
171
Universal Display
OLED
$4.28B
$386K 0.15%
+1,838
New +$323K
AZEK
172
DELISTED
The AZEK Co
AZEK
$384K 0.15%
9,122
-3,472
-28% -$161K
WTFC icon
173
Wintrust Financial
WTFC
$10.7B
$383K 0.15%
3,883
+845
+28% +$82.8K
OBDC icon
174
Blue Owl Capital
OBDC
$5.75B
$381K 0.15%
24,795
+5,537
+29% +$88.5K
PSX icon
175
Phillips 66
PSX
$88.2B
$375K 0.15%
2,656
-1,877
-41% -$278K

Similar funds

Alpha DNA Investment Management's Q2 2024 Portfolio in Review

As of Q2 2024, Alpha DNA Investment Management held 259 positions worth $257M, down 4.9% from $271M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Alpha DNA Investment Management withdrew a net $15.3M in Q2 2024, closing 57 positions and reducing 68 holdings. Its most notable exit was Cigna, an estimated $2.32M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Alpha DNA Investment Management opened a new position in Colgate-Palmolive worth $2.32M.

  • Alpha DNA Investment Management's largest Q2 2024 buy was Colgate-Palmolive: 23,939 shares worth $2.32M.
  • Alpha DNA Investment Management added most to Wells Fargo in Q2 2024, an estimated $2.53M increase.
  • Alpha DNA Investment Management's biggest Q2 2024 reduction was Microsoft, cutting an estimated $2.62M.
  • Alpha DNA Investment Management fully exited Cigna in Q2 2024, selling an estimated $2.32M.
  • Alpha DNA Investment Management's ten largest holdings make up 43% of its $257M portfolio in Q2 2024.
  • Alpha DNA Investment Management opened 67 new positions and closed 57 in Q2 2024.
  • Alpha DNA Investment Management's portfolio value fell 4.9% quarter-over-quarter to $257M.

Based on Alpha DNA Investment Management's 13F filing for Q2 2024, filed 14 Aug 2024.